Amarin (AMRN) gains 5% after announcing the FDA has accepted a New Drug Application for its...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN) gains 5% after announcing the FDA has accepted a New Drug Application for its AMR101 drug, which aims to treat patients with high triglyceride levels. Shares rose last week on positive Phase 3 trial data.